SOX9 and pancreatic neoplasm: Therefore, taking into account the significant intratumoral and intertumoral heterogeneity of PDAC, we conducted a relative assessment of changes that occur after the downregulation of SOX9 expression via siRNA in different pancreatic cancer cell lines.